Single-centre, single-blind, randomized, active-controlled phase-3 non-inferiority study to investigate the safety and efficacy of the cardioplegic solution CardioplexolTM

ABSTRACT:

SUBMITTER: Tevaearai Stahel H 

PROVIDER: S-EPMC12128416 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature